Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Applying to Emory University/Winship Cancer Institute · Atlanta, Georgia
Answer a few short questions to share with the research team.